Clifford Swan Investment Counsel LLC Makes New Investment in Globe Life Inc. (NYSE:GL)

Clifford Swan Investment Counsel LLC purchased a new stake in shares of Globe Life Inc. (NYSE:GLFree Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 1,697 shares of the company’s stock, valued at approximately $207,000.

A number of other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. grew its position in Globe Life by 1.7% in the third quarter. Vanguard Group Inc. now owns 10,881,775 shares of the company’s stock worth $1,183,175,000 after acquiring an additional 181,824 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Globe Life by 4.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,247,993 shares of the company’s stock valued at $461,884,000 after acquiring an additional 168,127 shares in the last quarter. Cooke & Bieler LP boosted its position in Globe Life by 2.0% during the fourth quarter. Cooke & Bieler LP now owns 2,357,839 shares of the company’s stock worth $286,996,000 after purchasing an additional 45,227 shares during the period. Invesco Ltd. lifted its stake in shares of Globe Life by 3.7% in the third quarter. Invesco Ltd. now owns 1,901,013 shares of the company’s stock worth $206,697,000 after buying an additional 67,753 shares during the last quarter. Finally, Equity Investment Corp grew its stake in shares of Globe Life by 1.9% in the third quarter. Equity Investment Corp now owns 727,657 shares of the company’s stock worth $79,118,000 after acquiring an additional 13,876 shares during the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Price Performance

NYSE:GL opened at $80.69 on Tuesday. The firm has a market cap of $7.59 billion, a PE ratio of 7.72 and a beta of 0.78. The company’s 50-day moving average price is $100.90 and its two-hundred day moving average price is $113.80. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.36. Globe Life Inc. has a 12 month low of $38.95 and a 12 month high of $132.00.

Globe Life (NYSE:GLGet Free Report) last released its quarterly earnings results on Monday, April 22nd. The company reported $2.78 EPS for the quarter, missing analysts’ consensus estimates of $2.79 by ($0.01). Globe Life had a return on equity of 23.91% and a net margin of 18.07%. The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter last year, the company earned $2.53 earnings per share. The firm’s revenue was up 7.2% on a year-over-year basis. On average, equities analysts anticipate that Globe Life Inc. will post 11.72 EPS for the current fiscal year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 1st. Shareholders of record on Friday, July 5th will be given a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 1.19%. The ex-dividend date of this dividend is Friday, July 5th. Globe Life’s payout ratio is presently 9.17%.

Insiders Place Their Bets

In related news, EVP Rebecca E. Zorn sold 2,320 shares of the business’s stock in a transaction that occurred on Thursday, April 25th. The shares were sold at an average price of $77.30, for a total value of $179,336.00. Following the completion of the transaction, the executive vice president now owns 10,220 shares in the company, valued at approximately $790,006. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Rebecca E. Zorn sold 2,320 shares of Globe Life stock in a transaction dated Thursday, April 25th. The stock was sold at an average price of $77.30, for a total value of $179,336.00. Following the completion of the sale, the executive vice president now directly owns 10,220 shares in the company, valued at $790,006. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director David A. Rodriguez acquired 1,500 shares of the company’s stock in a transaction on Wednesday, April 24th. The shares were purchased at an average cost of $79.72 per share, with a total value of $119,580.00. Following the completion of the acquisition, the director now directly owns 4,192 shares in the company, valued at approximately $334,186.24. The disclosure for this purchase can be found here. Insiders own 1.51% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on GL. Piper Sandler dropped their price objective on shares of Globe Life from $130.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, April 24th. JPMorgan Chase & Co. boosted their price target on Globe Life from $133.00 to $136.00 and gave the company an “overweight” rating in a research note on Thursday, February 8th. Wells Fargo & Company reduced their price objective on Globe Life from $132.00 to $108.00 and set an “overweight” rating for the company in a research report on Wednesday, April 24th. StockNews.com cut Globe Life from a “buy” rating to a “hold” rating in a research report on Saturday, April 20th. Finally, Keefe, Bruyette & Woods raised Globe Life from a “market perform” rating to an “outperform” rating and reduced their target price for the stock from $130.00 to $110.00 in a research report on Wednesday, April 24th. Five research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $114.33.

Check Out Our Latest Report on Globe Life

Globe Life Profile

(Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Further Reading

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GLFree Report).

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.